KIR3DL1 and myeloid sarcoma: Table 3 and Fig 2 show the results of the comparison between the KIR entropy SKIR of a cohort of 619 healthy controls and a group of 270 MS patients, stratified into two groups of patients affected by RRMS or PPMS.